Ghent-based Azalea Vision has announced the first closing of its €15M Series A funding round, raising €9M to initiate its First-in-Human clinical trial, validating its eye care technology. The company is working towards FDA approval and further clinical trials, with industry veteran Robert J. Dempsey appointed as Chairman to guide strategic growth. Established in 2021, Azalea Vision focuses on developing the first medical-grade smart lens platform that integrates advanced technologies to enhance vision care, supported by various MedTech and HealthTech investors.
Azalea Vision's first closing of its €15M Series A funding round enables the clinical trials of its revolutionary eye care technology, aimed at FDA approval.
Robert J. Dempsey, with over three decades in eyecare, appointed as Chairman to guide Azalea Vision's strategic growth as it pushes forward with its innovative platform.
Collection
[
|
...
]